Emergent Biosolutions Inc (EBS) — Strategic Asset Allocation Index
Emergent Biosolutions Inc (EBS) has a Strategic Asset Allocation Index of 37.3% as of September 2025. Strategic assets (PP&E of $217.00 Million plus long-term investments of $-) total $217.00 Million, measured against net assets of $582.50 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Emergent Biosolutions Inc Strategic Asset Allocation Index (2004–2024)
This chart shows how Emergent Biosolutions Inc's Strategic Asset Allocation Index has evolved across 21 annual periods from 2004 to 2024. As of September 2025, the index stands at 37.3%, representing strategic assets of $217.00 Million against net assets of $582.50 Million USD. Explore how efficiently does Emergent Biosolutions Inc generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Emergent Biosolutions Inc (2004–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Emergent Biosolutions Inc from 2004 to 2024, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Emergent Biosolutions Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 58.5% | $282.30 Million | $282.30 Million | $- | $482.80 Million | ▼ -3.0 pp |
| 2023 | 61.5% | $399.00 Million | $399.00 Million | $- | $649.30 Million | ▲ +2.3 pp |
| 2022 | 59.1% | $817.60 Million | $817.60 Million | $- | $1.38 Billion | ▲ +9.5 pp |
| 2021 | 49.6% | $800.10 Million | $800.10 Million | $- | $1.61 Billion | ▲ +5.1 pp |
| 2020 | 44.5% | $644.10 Million | $644.10 Million | $- | $1.45 Billion | ▼ -5.3 pp |
| 2019 | 49.8% | $542.30 Million | $542.30 Million | $- | $1.09 Billion | ▼ -0.6 pp |
| 2018 | 50.5% | $510.20 Million | $510.20 Million | $- | $1.01 Billion | ▲ +5.8 pp |
| 2017 | 44.6% | $407.21 Million | $407.21 Million | $- | $912.35 Million | ▼ -18.5 pp |
| 2016 | 63.1% | $376.45 Million | $376.45 Million | $- | $596.21 Million | ▲ +12.9 pp |
| 2015 | 50.3% | $331.86 Million | $331.86 Million | $- | $660.02 Million | ▼ -6.5 pp |
| 2014 | 56.8% | $313.98 Million | $313.98 Million | $- | $553.20 Million | ▲ +2.7 pp |
| 2013 | 54.0% | $264.24 Million | $264.24 Million | $- | $489.17 Million | ▼ -0.7 pp |
| 2012 | 54.7% | $241.76 Million | $241.76 Million | $- | $442.13 Million | ▲ +4.5 pp |
| 2011 | 50.1% | $208.97 Million | $208.97 Million | $- | $416.73 Million | ▲ +9.3 pp |
| 2010 | 40.9% | $152.70 Million | $152.70 Million | $- | $373.56 Million | ▼ -13.2 pp |
| 2009 | 54.1% | $131.83 Million | $131.83 Million | $- | $243.81 Million | ▼ -8.5 pp |
| 2008 | 62.5% | $124.66 Million | $124.66 Million | $- | $199.35 Million | ▼ -1.9 pp |
| 2007 | 64.4% | $110.22 Million | $110.22 Million | $- | $171.16 Million | ▲ +7.9 pp |
| 2006 | 56.5% | $78.17 Million | $78.17 Million | $- | $138.47 Million | ▲ +5.2 pp |
| 2005 | 51.3% | $30.64 Million | $30.64 Million | $- | $59.74 Million | ▼ -67.5 pp |
| 2004 | 118.8% | $27.27 Million | $27.27 Million | $- | $22.95 Million | — |